Primary Site >> Colorectal Cancer
Gene >> IMP3
| 1. | |||||||||||
| Journal: | Ann Surg Oncol. 2009 Dec;16(12):3499-506. | ||||||||||
| Title: | IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. | ||||||||||
| Author: | Li, Dawei|Yan, Dongwang|Tang, Huamei|Zhou, Chongzhi|Fan, Junwei|Li, Shuxia|Wang, Xiaoliang|Xia, Jun|Huang, Fei|Qiu, Guoqiang|Peng, Zhihai | ||||||||||
| PMID: | 19672661 | ||||||||||
| 2. | |||||||||||
| Journal: | Eur J Cancer. 2012 Dec;48(18):3405-13. | ||||||||||
| Title: | Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. | ||||||||||
| Author: | Lochhead, Paul|Imamura, Yu|Morikawa, Teppei|Kuchiba, Aya|Yamauchi, Mai|Liao, Xiaoyun|Qian, Zhi Rong|Nishihara, Reiko|Wu, Kana|Meyerhardt, Jeffrey A|Fuchs, Charles S|Ogino, Shuji | ||||||||||
| PMID: | 22840368 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncol Lett. 2013 Sep;6(3):740-744. | ||||||||||
| Title: | Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. | ||||||||||
| Author: | Lin, Lijuan|Zhang, Jinhui|Wang, Yan|Ju, Weiei|Ma, Yibing|Li, Lina|Chen, Litian | ||||||||||
| PMID: | 24137402 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncoscience. 2015 Jul 1;2(6):607-14. | ||||||||||
| Title: | Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target. | ||||||||||
| Author: | Shantha Kumara, Hmc|Kirchoff, Daniel|Caballero, Otavia L|Su, Tao|Ahmed, Aqeel|Herath, Sonali Ac|Njoh, Linda|Cekic, Vesna|Simpson, Andrew J|Cordon-Cardo, Carlos|Whelan, Richard L | ||||||||||
| PMID: | 26244168 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2015 Sep 1;8(9):11024-32. eCollection 2015. | ||||||||||
| Title: | IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage. | ||||||||||
| Author: | Wei, Qingzhu|Huang, Xiaoping|Fu, Bo|Liu, Jianghuan|Zhong, Ling|Yang, Qiao|Zhao, Tong | ||||||||||
| PMID: | 26617820 | ||||||||||
| 6. | |||||||||||
| Journal: | Hum Pathol. 2017 Jun;64:137-144. | ||||||||||
| Title: | IMP3 expression in biopsy specimens as a diagnostic biomarker for colorectal cancer. | ||||||||||
| Author: | Wei, Qingzhu|Zhou, Hui|Zhong, Ling|Shi, Liyin|Liu, Jianghuan|Yang, Qiao|Zhao, Tong | ||||||||||
| PMID: | 28412210 | ||||||||||
| 7. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Jun 6;10:2849-2863. | ||||||||||
| Title: | Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. | ||||||||||
| Author: | Chen, Luyao|Xie, Yongpeng|Li, Xintao|Gu, Liangyou|Gao, Yu|Tang, Lu|Chen, Jianwen|Zhang, Xu | ||||||||||
| PMID: | 28652767 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncol Lett. 2017 Dec;14(6):7304-7310. | ||||||||||
| Title: | Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer. | ||||||||||
| Author: | Huang, Xiaoping|Wei, Qingzhu|Liu, Jianghuan|Niu, Hongling|Xiao, Gang|Liu, Lixin | ||||||||||
| PMID: | 29344167 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Med Rep. 2018 Jan;17(1):1065-1070. | ||||||||||
| Title: | Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. | ||||||||||
| Author: | You, Shuping|Guan, Yun|Li, Weihong | ||||||||||
| PMID: | 29115492 | ||||||||||
| 10. | |||||||||||
| Journal: | Oncol Rep. 2018 Jan;39(1):3-12. | ||||||||||
| Title: | IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues. | ||||||||||
| Author: | Burdelski, Christoph|Jakani-Karimi, Nilofar|Jacobsen, Frank|Moller-Koop, Christina|Minner, Sarah|Simon, Ronald|Sauter, Guido|Steurer, Stefan|Clauditz, Till S|Wilczak, Waldemar | ||||||||||
| PMID: | 29115542 | ||||||||||